Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
Clinical trial NCT01897532 · COMPLETED
Trial details
- NCT number
- NCT01897532
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-10
- Primary completion
- 2018-01-18
- Enrollment
- 6991
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.